638 related articles for article (PubMed ID: 23878061)
21. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
[TBL] [Abstract][Full Text] [Related]
22. Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).
Rajasekaran D; Jariwala N; Mendoza RG; Robertson CL; Akiel MA; Dozmorov M; Fisher PB; Sarkar D
J Biol Chem; 2016 May; 291(20):10736-46. PubMed ID: 26997225
[TBL] [Abstract][Full Text] [Related]
23. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
Huynh H; Chow PK; Ooi LL; Soo KC
Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma.
He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L
Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097
[TBL] [Abstract][Full Text] [Related]
25. SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma.
Cui X; Zhao C; Yao X; Qian B; Su C; Ren Y; Yao Z; Gao X; Yang J
RNA Biol; 2018; 15(10):1364-1375. PubMed ID: 30321081
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
[TBL] [Abstract][Full Text] [Related]
27. Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression.
Li GQ; Guo WZ; Zhang Y; Seng JJ; Zhang HP; Ma XX; Zhang G; Li J; Yan B; Tang HW; Li SS; Wang LD; Zhang SJ
Oncotarget; 2016 Jan; 7(3):2462-74. PubMed ID: 26575167
[TBL] [Abstract][Full Text] [Related]
28. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
29. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
[TBL] [Abstract][Full Text] [Related]
30. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma.
Yeung BH; Shek FH; Lee NP; Wong CK
PLoS One; 2015; 10(10):e0139977. PubMed ID: 26469082
[TBL] [Abstract][Full Text] [Related]
31. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
[TBL] [Abstract][Full Text] [Related]
32. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
33. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
[TBL] [Abstract][Full Text] [Related]
34. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
Sun H; Gao Y; Lu K; Zhao G; Li X; Li Z; Chang H
World J Surg Oncol; 2015 Oct; 13():307. PubMed ID: 26499380
[TBL] [Abstract][Full Text] [Related]
36. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
Law PT; Ching AK; Chan AW; Wong QW; Wong CK; To KF; Wong N
Carcinogenesis; 2012 Jun; 33(6):1134-41. PubMed ID: 22431718
[TBL] [Abstract][Full Text] [Related]
37. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.
Hung TM; Ho CM; Liu YC; Lee JL; Liao YR; Wu YM; Ho MC; Chen CH; Lai HS; Lee PH
PLoS One; 2014; 9(2):e89446. PubMed ID: 24586785
[TBL] [Abstract][Full Text] [Related]
39. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
[TBL] [Abstract][Full Text] [Related]
40. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]